These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Direct thrombin inhibitors (part 1 of 2). Arora UK; Dhir M J Invasive Cardiol; 2005 Jan; 17(1):34-8. PubMed ID: 15640538 [No Abstract] [Full Text] [Related]
3. Direct thrombin inhibitors: clinical uses, mechanism of action, and laboratory measurement. Rhea JM; Molinaro RJ MLO Med Lab Obs; 2011 Aug; 43(8):20, 22, 24. PubMed ID: 21936409 [No Abstract] [Full Text] [Related]
4. Novel anticoagulants based on direct inhibition of thrombin and factor Xa. Gardell SJ; Sanderson PE Coron Artery Dis; 1998; 9(2-3):75-81. PubMed ID: 9647407 [No Abstract] [Full Text] [Related]
5. Synthetic direct thrombin inhibitors in unstable angina - more questions than answers. Oberhoff M; Karsch KR Eur Heart J; 1999 Aug; 20(15):1058-60. PubMed ID: 10413631 [No Abstract] [Full Text] [Related]
6. Antithrombotic effect of synthetic thrombin inhibitors. Klöcking HP Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(4):483-7. PubMed ID: 4121341 [No Abstract] [Full Text] [Related]
7. Direct thrombin inhibitors: patents 2002-2012 (Review). Kong Y; Chen H; Wang YQ; Meng L; Wei JF Mol Med Rep; 2014 May; 9(5):1506-14. PubMed ID: 24604304 [TBL] [Abstract][Full Text] [Related]
11. New anticoagulant agents: direct thrombin inhibitors. Nutescu EA; Shapiro NL; Chevalier A Clin Geriatr Med; 2006 Feb; 22(1):33-56, viii. PubMed ID: 16377466 [TBL] [Abstract][Full Text] [Related]
12. Use of direct thrombin inhibitors in acute coronary syndrome. Nemergut C; Cheng JW Clin Ther; 2000 Aug; 22(8):937-48; discussion 898. PubMed ID: 10972630 [TBL] [Abstract][Full Text] [Related]
13. [Present and future developments of antithrombotic agents]. Montalescot G Arch Mal Coeur Vaiss; 2006 Feb; 99 Spec no.3():17-22. PubMed ID: 16553239 [TBL] [Abstract][Full Text] [Related]
14. Development of direct thrombin inhibitors in comparison with glycosaminoglycans. Markwardt F Semin Thromb Hemost; 2001 Oct; 27(5):523-30. PubMed ID: 11668423 [TBL] [Abstract][Full Text] [Related]
16. Progress in the design of low molecular weight thrombin inhibitors. Srivastava S; Goswami LN; Dikshit DK Med Res Rev; 2005 Jan; 25(1):66-92. PubMed ID: 15389730 [TBL] [Abstract][Full Text] [Related]
17. The influence of direct thrombin inhibitors on the formation of platelet-leukocyte aggregates and tissue factor expression. Christersson C; Johnell M; Siegbahn A Thromb Res; 2010 Oct; 126(4):e327-33. PubMed ID: 20451956 [TBL] [Abstract][Full Text] [Related]
18. [Direct thrombin inhibitors]. Bornkessel B Med Monatsschr Pharm; 1997 Apr; 20(4):86-9. PubMed ID: 9198724 [No Abstract] [Full Text] [Related]
19. Pharmacology and therapeutic applications of hirudin, a new anticoagulant. Glusa E Kidney Int Suppl; 1998 Feb; 64():S54-6. PubMed ID: 9475490 [No Abstract] [Full Text] [Related]
20. Antithrombins: their potential as antithrombotic agents. Weitz JI; Hirsh J Annu Rev Med; 1992; 43():9-16. PubMed ID: 1374601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]